Posard Matthew L. Insider Trading -- Recent SEC Form 4 Transactions
Posard Matthew L. (CIK 1543792) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-10-02). Recent activity: Sell HALO (3,300 shares), Sell HALO (1,100 shares), Sell HALO (100 shares), Sell HALO (730 shares), Sell HALO (3,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-02 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Sell | 3,300 | $357,898 |
| 2026-10-02 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Sell | 1,100 | $120,526 |
| 2026-10-02 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Sell | 100 | $11,004 |
| 2026-10-02 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Sell | 730 | $78,233 |
| 2026-09-17 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Sell | 3,000 | $320,484 |
| 2026-09-17 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Sell | 3,100 | $329,009 |
| 2026-09-17 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Sell | 8,896 | $961,124 |
| 2026-09-17 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Sell | 4,000 | $435,964 |
| 2026-05-07 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Buy | 3,796 | $0 |
| 2025-05-02 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Buy | 4,165 | $0 |
Source: SEC Form 4 filings · as of 2026-10-02